Publication:
THE INFERTILITY INDUSTRY: INSPIRING TECHNOLOGY GIVES BIRTH TO COMPLEX MORAL UNCERTAINTIES

Thumbnail Image

Date

2002

Published Version

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

THE INFERTILITY INDUSTRY: INSPIRING TECHNOLOGY GIVES BIRTH TO COMPLEX MORAL UNCERTAINTIES (2002 Third Year Paper)

Research Data

Abstract

Assisted reproductive technologies (ART) are rapidly advancing, permitting more couples and individuals to overcome their infertility. These advances, taking place largely outside the reach or view of government regulation or oversight, create numerous important consequences that raise serious ethical considerations. There is a need for consumer protection for infertile couples, as well as the assurance of the safety and efficacy of techniques and donated human cellular materials. Most fundamentally the moral questions raised by the techniques and their consequences must be addressed. The legal status of embryos, the many problems that arise from multiple fetus pregnancies that result from over-implantation of embryos, the non-therapeutic genetic screening that the technology permits, and the ever-increasing maternal age all raise fundamental ethical dilemmas. These dilemmas are not being resolved because any discussion or resolution treads close to the emotional and politically charged politics of abortion. This paper highlights the various consequences of ART, identifies the ethical consequences, and discusses the proper forum for their possible resolution.

Description

Other Available Sources

Keywords

Food and Drug Law, ART, infertility

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories